K905623

Substantially Equivalent

CK-MB IMMUNOASSAY CONTROL

Applicant: Seradyn, Inc.
Product code: JJT
Advisory panel: Clinical Chemistry
Date received: 1990-12-14
Decision date: 1991-02-22
Decision: Substantially Equivalent
Clearance type: Traditional
Location: Indianapolis, IN, US

Download summary PDF View on FDA.gov ↗

Data sourced from openFDA. This site is unofficial and independent of the FDA.